Copper(II) complexes of azo- based ligands and their biological activities.
Abstract
Copper(II) complexes possess relatively a broad spectrum of medicinal importance with less toxicity. It is important to note that, in this chapter, copper(II) is selected as chelating central metal atom considering its current reputation to design such bio-active compounds due to its; (i) permits in realizing stable coordination compound, (ii) diverse coordinating capability with oxygen (O), nitrogen (N), sulfur (S) and phosphorus (P) donor ligands, and (iii) exhibits potentially better biological activity. Therefore, the presented chapter offers the up-to-date advancement and future perspective of bio-active copper(II) complexes derived from Schiff base of azo- and phenyl hydrazine-based ligands and their derivatives. To showcase the existing trend of these classes of bio-active compounds, due to the wide depth of the literature, selected seminal compounds exhibiting outstanding biological activity are discussed in detail. Recent studies establish that azo- and phenyl hydrazine-based bio-active copper(II) complexes are among the promising candidates that are expected to replace the conventional antibiotics which are suffering from side effects as well as microbial resistance. However, the collaborative efforts of chemists and biotechnologists are still needed to realize their real world application.
Keywords
- bio-active compounds
- copper(II)
- ligands
- copper(II) complexes
- azo- and phenyl hydrazine ligands
1. Introduction
Medicinal inorganic chemistry deals with searching and designing of additional therapeutic alternatives not accessible to the organic compound counterparts, in which metal complexes have been extensively investigated. This is because of the wide range of coordination numbers, oxidation state, coordination geometries, and accessible redox states, which are the intrinsic properties of the Lewis acid central metal ions as well as the different coordination modes of donor atoms (N, O, S, and so on) of the Lewis base ligands offer the medicinal inorganic chemist a large opportunity to extensively exploited [1, 2]. Of the transition metals, copper plays a crucial part in biological processes in mitochondria and cell [3, 4]. For example, Figure 1 demonstrates copper homeostasis i.e. the mode of copper uptake, distribution as well as removal in mammalian cells. Copper can also form stable redox-active biological compounds with a variety of ligands that contain donor atoms like O, S, or N [6]. Moreover, the biological accessible redox potential of copper as Cu(II)/Cu(I) redox pairs have biologically significant implications such as metallo-nucleases [7, 8]. Copper is not only necessary for numerous biological processes but also a powerful anti-microbial tool that can be used to combat invasive diseases [9]. Consequently, copper complexes have been extensively studied for their potential biological activity such as antimicrobial [10], antiviral [11], anti-inflammatory [12], and antifungal [13] properties.
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F1.png)
Figure 1.
Copper homeostasis and its mode of uptake, distribution as well as removal in mammalian cells. After reduction of Cu(II) to Cu(I) form, it enters the cell via the copper importer Ctr1 and then passed on to the chaperones COX17, CCS, and ATOX1, which deliver the copper to the cytosolic SOD1, COX in the mitochondria and to ATP7A/B at the TGN, respectively. Moreover, copper binds to cellular the antioxidant (MTs and GSH) that helps to prevent the formation of free catalyzing copper ROS. At the TGN, copper is amalgamated with copper-dependent enzymes (such as ceruloplasmin) that migrate through the secretion pathway. Under intracellular copper elevated condition, its excretion is facilitated via ATP7A as well as ATP7B circulation from the TGN to the plasma membrane, while the transporter Ctr1 is suppressed and is subsequently degraded. Ctr2 can also increase the generation of tCtr1, which facilitate endosomal copper transport to the cytoplasm resulting in the diminishing of the intracellular copper accretion [5]. Abbreviations: Trans-Golgi network = TGN, ATP7A/B = copper transporting ATPase A/B, ATOX1 = antioxidant protein, COX = cytochrome c oxidase, COX17 = cytochrome c oxidase copper chaperone, CCS = copper chaperone for SOD1, ROS = reactive oxygen species, Ctr1/2 = copper transporter 1/2, MT = metallothioneins, SOD1 = Cu/Zn–superoxide dismutase, GSH = glutathione, and tCtr1 = truncated Ctr1.
Researchers have been realized that, compared to the ligands, metal complexes could possess a greater biological activity with lower toxicity [14]. Of the metal complexes, copper complexes mainly depend on the oxidation state i.e. copper(I) and copper(II) as well as nature of the ligands and their donor atoms [9]. Like other transition metal ions, copper has various oxidation states, i.e. I, II, and III, of which the copper(II) with a d9 system of electronic configuration is the most favorable and relatively stable oxidation state. Considering its broad spectrum of bioactivity application, copper(II) is relatively vital in medicinal and pharmaceutical fields. Apart from the central metals, a rational designing of the ligands is also a very important step in developing bioactive complexes. For this reason, several ligands have been employed such as, Schiff bases ligands with multi dentate scaffold bearing imine nitrogen (C=N) which can be realized by simple condensation of aldehydes or ketones. Moreover, azo-based ligands possessing the azo functional group (N=N) moiety which can be also prepared by diazotization-condensation [15] as well as hydrazone-based ligands which are another class of Schiff base compounds containing hydrazine moiety (C=N–N) which can be synthesized by hydrazine-aldehyde/ketone condensation or Japp-Klingemann reaction [16, 17] have been also employed. The strategic synthesis of such ligands is well documented and extensively explored. Therefore, due to their straightforward synthesis route of these classes of ligands, their detailed synthesis strategy is omitted to avoid redundancy and only the type of ligands covered in this chapter.
Copper(II) complexes can display a substantial biological activity employing different ligands such as Schiff bases containing azo-, hydrazine-, and hetrocycles- moiety. These types of ligands containing imine moiety can form a stable metal coordination complexes which are responsible for broad spectrum of applications of which biological activity is one application field [18]. The presented chapter offers the current advancement and forwards the future perspective of copper(II) complexes of both azo- and hydrazine-based ligands and their biological importance. Appreciating all efforts that have been done so far, due to the wide depth of the literature, only selected seminal reports of azo- as well as phenyl hydrazine-based copper(II) complexes exhibiting superior biological activity are considered in this chapter. Additionally, more emphasis is also given to the complexes which are structurally well characterized (using single crystal XRD) unless the complexes reported with powder chemistry structural exhibited outstanding biological activity. Finally, the theoretical consideration of some selected seminal works is also incorporated to probe their relationship with the experimental aspect.
2. Bio-active copper(II) compounds
The bio-activity, biocompatibility as well as versatile coordination chemistry nature of the copper metal offer an opportunity for realizing bio-active copper(II) complexes which is usually achieved via enhancing the initial bio-activity of the ligand such as Azo-Schiff base ligands [15] and hydrazone based ligands [19]. Incorporating two or more diverse chromophores into the ligand could potentially enhance the physicochemical as well as the biological properties of the desired ligands and their respective metal complexes [15]. Azo are typically Schiff base ligands possessing a distinct chromophore group (N=N) which is responsible for diverse potential range of applications such as dyes [20] and biological [21] applications. Moreover, hydrazine and/or hydrazine based ligands displaying keto-enol tautomerism are another class of Schiff base ligands where the complexation of copper(II) with such biologically active ligands offers the opportunity of improving the efficacy of anti-microbial activity via evading the drug resistant pathogens [19, 22]. In this chapter, the biological activity of various N–N azo- as well as phenyl hydrazine ligand and/or hydrazone derivatives for copper (II) complex is summarized, including some copper(II) complexes based drugs commonly used as antibiotics, antimicrobials, and anti-inflammatory remedies.
2.1 Azo-based bio-active copper(II) complexes
Apart from industrial applications, dyes mainly azo-dyes possess massive biological applications (Figure 2) confirming the versatility of these class of compounds. Recently, the biological application of azo-based ligands and their metal complexes are getting much attention due to the presence of the optically and biologically active azo- functional group. Azo compounds are commonly prepared by diazotization and coupling i.e. diazotization of an aromatic primary amine followed by coupling with electron-rich nucleophile such as amino and hydroxyl group under alkaline conditions. Due to straight forward synthesis of the azo-based multi dentate ligands and their readily coordination flexibility, azo-based copper(II) bio-active complexes has been extensively explored [15, 21, 23]. For example, more recently Mady et al. reported a series of o-vanillin-azo (OV-AZO) based ligand prepared by condensation of 4-aminoazobenzene and o-vanillin and their transition metal complexes (Mn(II), Ni(II), Co(II), Cu(II), Zn(II), and Zr(IV)) for their anticancer and antimicrobial activity (Figure 3) [23]. The obtained results showed that, in comparison to the free corresponding azo-based ligand, of the other transition metal complexes, the copper(II) complex exhibited the maximum cytotoxic activity of an half maximal inhibitory concentration (
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F2.png)
Figure 2.
Schematic illustration of azo-dyes and their biological as well as industrial applications.
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F3.png)
Figure 3.
Proposed structures of the azo-based ligand (OV-AZO) and its transition metal complexes [23].
Kurtoglu and coworkers reported azo-azomethine based ligands of Cu(II) complexes and their antioxidant and cytotoxicity against human uterus carcinoma cells lines (Figure 4) [24]. Interestingly, all the ligands and the complexes exhibited better antiproliferative activities at 25, 50, and 100 μgmL−1 concentrations where complexation of the ligands with the copper(II) ion slightly declined their anticancer properties which could be due to the hindering of the imine, phenolic and methoxy groups. Similarly, the antioxidant properties of the ligands were slightly better than the copper(II) complexes. Moreover, Krishnamurthy and coworkers reported an isonicotine hydrazide based azo- ligand and its transition (Cu(II), Co(II), and Ni(II)) metal complexes with octahydral geometry displaying biological activity such as, human breast cancer cells (MDA-MB 231) where MDA stands for M.D. Anderson and MB stands for mammalian breast (Figure 5), as well as deoxyribonucleic acid (DNA) cleavage activity [25]. Scanning electron microscope (SEM) images revealed that the presence of variation in ligand and metal complexes surface morphology which could be because of the change of metal ion i.e. broken rock like, and ice block like structure for ligand and copper(II) complex, respectively as well as Cotton-like filamentary morphology for both cobalt(II) and nickel(II) complexes (Figure 5, bottom). Of the transition metal complexes, copper(II) complex exhibited the highest biological activity against all the investigated cell lines confirming that biological activities depends on the type of the central metal ion.
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F4.png)
Figure 4.
Crystal structure of the azo-azomethine based ligands, their Cu(II) complexes and their antiproliferative activities where 1 is the azo-aldehyde, 2-4 are the ligands (R = 3-ethylaniline or 3-CH2CH3; 4-ethylaniline or 4-CH2CH3, and 4-isopropylaniline or 4-CH(CH3)2), 5-7 are the complexes and 5-Fu is fluorouracil [24].
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F5.png)
Figure 5.
Schematic representation of the metal complexes and their cytotoxicity effect by methyl thiazolyl tetrazolium (MTT) assay of ligand as well as the complexes on breast cancer cells (MDA-MB-231) cells (top) as well as their SEM morphological structure of the ligand (HL) and the corresponding metal complexes (bottom) [25].
Keshavayy and coworkers reported benzothiazole based azo- ligand with indol wing and its transition metal complexes (Cu(II), and Ni(II) with distorted square planar, Co(II), and Fe(III) with octahedral as well as Zn(II) with tetrahedral geometry) for their potential antimicrobial, antitubercular as well as DNA cleavage activities (Figure 6) [26]. Apart from the investigated biological activities, all the formulated compounds demonstrated a promising anti-tubercular activity i.e. against
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F6.png)
Figure 6.
Proposed schematic structures of the metal complexes and the anti-tubercular activity of the ligand and its metal complexes [26].
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F7.png)
Figure 7.
The proposed molecular geometries for the metal complexes and their DNA (plasmid pUC18) cleavage activity; M = standard DNA, C = control DNA (untreated pUC 18), 1 = azo- based ligand, and its complexes (1a = Cu(II), 1b = Co(II) and 1c = Ni(II), respectively) (top). The molecular geometries (calculated) of the ligand (L) as well as its complexes (bottom) [27].
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F8.png)
Figure 8.
The proposed molecular geometries for the metal complexes and their biological activity [28].
More recently, copper(II) and cobalt(II) complexes of azo- ligand obtained via the diazotization reaction of 2-amino pyridine with pyrazolone and their DNA cleavage and antibacterial (Klebsiella pneumonia, and
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F9.png)
Figure 9.
The proposed molecular geometries for the metal complexes, DNA cleavage of by the Cu(II), and Co(II) complexes at body temperature where lane 1 DNA alone; lane 2 = DNA with 40 μl of copper(II) complex; lane 3 = DNA with 60 μl of copper(II) complex; lane 4 = DNA with 40 μl of cobalt(II) complex; lane 5 = DNA with 60 μl of cobalt(II) complex; form I = supercoiled and form II = nicked circular DNA, respectively as well as zone of inhibition of the azo- ligand and their metal complexes against (A)
More recently, our group also reported an azo- ligands possessing pyridone moiety with long aliphatic chain and their respective nitro and methyl group substituent as well as solvent dependent copper(II) complexes (elongated octahedral geometry) targeting its potential inhibitory against Alzheimer’s disease in comparison with Donepezil drug [21]. Our findings revealed that the binding affinity of the ligand as well as its copper(II) complexes were found with 1EVE ranges from −9.6 to −8.3 kcal/mol while −10.9 kcal/mol is for Donepezil drug suggesting our complexes could be promising drug candidates for Alzheimer’s disease. Moreover, comparing to both complexes, the Donepezil drug and ligands were found functioning as carcinogenic.
Recently, in continuation of our work on azo- ligands owning pyridone moiety, we report a diazenyl pyridinone based heterocyclic ligands and their Cu(II) complexes (octahedral geometry) for their potential antimicrobial, anticancer, and antioxidant properties (Figure 10) [30]. Our results revealed that the complexes showed better antitumor activity as well as selectivity index against the human primary hepatocytes THLE-2 and breast adenocarcinoma cells MCF-7 than the reference doxorubicin. Moreover, the prepared compounds exhibited significant anti-bacterial and anti-fungal properties (Figure 11, right).
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F10.png)
Figure 10.
Schematic illustration of the synthetic route of the copper(II) complexes employing the azo- ligand (top); the molecular structure of complexes of CuL1 (CuO2N4-octahedron) and CuL2 (CuO4N2-octahedron) (middle); as well as (a) simultaneous docking into the binding pocket of the 1EVE under similar conditions for the the superpositions of azo- ligands (L1H and L2H), complexes (CuL1 and CuL2) and donepezil drug (orange color) appeared in each window in comparison to the appearance of each ligand, (b) CuL2 and donepezil; (c) all molecules and donepezil; (b) CuL2 and donepezil; (d) CuL1 and donepezil; (e) L1H and donepezil; and (f) L2H and donepezil [21].
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F11.png)
Figure 11.
Schematic illustration and the optimized molecular structure of the copper(II) complexes (left); cell viability results of copper(II) complexes against the human breast adenocarcinoma MCF-7 cells at different (0–100 μM) concentrations, anti-bacterial and anti-fungal activities [30].
More interestingly, the azo- pyridone moiety containing ligands and their copper(II) complexes are becoming biologically promising where Lađarević and coworkers also reported on a similar work by ligand substituent tuning strategy [31]. In this work, both complexes, the chloride substituted (Cu(II)-Cl) and methoxy substituted (Cu(II)-OCH3) was found to be promising compounds for the treatment of various types of cancer which could be considered as potential therapeutic candidates. Among the two complexes, The most favorable structure exhibiting the best docking potential toward both proteins was the complex Cu(II)-OCH3 bearing methoxy group. Moreover, the Cu(II)-OCH3 complexes exhibited the highest antioxidative activity compared with its parent ligand and the standard ascorbic acid antioxidant which could be due to the presence of an electron–donor methoxy group making this complex as a favorable antioxidant agent. This findings revealed that both anticancer and antioxidant activities exhibited substituent dependent biological activity where for the azo- pyridone moiety containing ligands an electron donating methoxy group was found favorable for designing copper(II) bio-active compound (Figure 12).
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F12.png)
Figure 12.
Optimized molecular structure of the copper(II) complexes of Cu(II)-Cl (a) and Cu(II)-OCH3 (b). Best docking poses with interacting residues, as well as intermolecular interactions of CuL-OCH3complex with VEGFR-2 (c) and Aurora kinase A (d) [31].
It have been witnessed that azo- based ligands (derived from o-vanillin, salicylic, isonicotinic, thiazole, indole, pyrazole, pyridinone, and their derivatives, for details see Section 2.1) and their copper(II) complexes are found to be a favorable candidates for realizing potentially promising bio-active compounds. Such compounds are expected to replace the conventional drags which are suffering from side effect and biological pathogens resistance. Due to the vast depth of the literature with regard to azo- based copper(II) bio-active complexes, we attempt to discuss some selected promising compounds in the above. Therefore, Table 1 below attempts to incorporate some other works which are discussed in the above in detail. Thus, we encourage readers to cross refer the compounds presented in Table 1 for further detailed structural insights as well as to refer recent comprehensive review detailing Azo- based transition metal complexes and their biological activity reported by Younas and coworkers [15].
Chemical formula* | Geometry | Characterization techniques | Biological activity | Refs. |
---|---|---|---|---|
[Cu(LOV-AZO)2] | Square planar | FTIR, UV–Vis, TGA | Antibacterial | [32] |
[Cu(L1OV-AZO)].3H2O | Square planar | UV–Vis, FTIR, XRD | Anticancer | [33] |
[Cu(L2OV-AZO)Cl].2H2O | Square planar | FTIR, UV–Vis, TGA, EPR, XRD | Antibacterial and Antifungal | [34] |
[Cu(LSAL-AZO)].H2O | Square planar (distorted) | UV–Vis, FTIR, MS | Molluscicidl | [35] |
[Cu(L1SAL-AZO)H2O] | Square planar (distorted) | FTIR, UV–Vis, MS, ESR, XRD | Antibacterial and Antifungal | [36] |
[Cu(L2SAL-AZO) H2O](OAc)2 | Tetrahedral/Square planar | FTIR, UV–Vis, TGA | Antibacterial | [37] |
[Cu(L3SAL-AZO)2(H2O)2] | Octahedral | UV–Vis, FTIR, ESI-MS | Antibacterial and Antifungal | [38] |
[Cu(LTSC-AZO)H2O] | FTIR, UV–Vis, TGA | Antibacterial | [39] | |
[Cu(LPYRI-AZO)DMF] | Square-pyramidal | ICP-OES, UV–Vis, FTIR, TGA, Single crystal X-ray | Antioxidant, and Anticancer | [31] |
[Cu(LPYRA-AZO)].nH2O | Octahedral | UV-Visible, FT-IR, NMR, MS, XRD | DNA cleavage and Antibacterial | [29] |
[Cu(LTHAI-AZO)] | Octahedral | FTIR, UV–Vis, TGA, ESR, XRD, MS, EDAX, SEM | Anticancer | [28] |
[Cu(LINDO-AZO)] | Square planar (distorted) | FTIR, UV–Vis, MS, ESR, XRD | DNA cleavage and Antibacterial | [26] |
[Cu(LNICO-AZO)].3H2O | Octahedral | FTIR, UV–Vis, MS, ESR, XRD | DNA cleavage and Cytotoxicity | [25] |
Table 1.
The abbreviated expressions in subscript position; OV, SAL, TSC, PYRI, PYRA, THAI, INDO, and NICO stands for o-vanillin, salicylic, thiosemicarbazide, pyridinone, pyrazole, thiazole, indole, nicotinic, and their derivatives respectively, for more structural details of the ligands, please refer the original article from the provided references.
2.2 Phenyl hydrazine- and hydrazone-based bio-active copper(II) complexes
Hydrozones are very essential intermediates for the synthesis of different heterocyclic compounds. Acid hydrazides as well as their derivatives are also another class of hydrazine based compounds which useful chemical synthons for synthesis of numerous heterocyclic compounds that with pronounced biological as well as pharmacological applications [40]. Apart from biological applications, Brady and Elsmie reported that, of the nitro-substituted phenylhydrazine, dinitrophenylhydrazine is a reddish yellow compound which has been used as an analytical reagent for the identification of carbonyl functional groups quantitatively [41] e.g. in biological samples [42]. This confirms that phenylhydrazine and their derivatives are good nucleophile for carbonyl ketones as well as aldehydes in the formation multi-functional hydrazone based ligands (Figure 13) and their metal complexes for different applications such as biological activity [16, 17]. Currently, hydrazone ligands possessing oxygen and nitrogen are under extensive exploration due to their ease of synthesis, chelating ability, potential biological as well as pharmacological applications [19, 40]. Amid the different metal ions, the divalent Cu(II), Ni(II), Co(II), and Zn(II) are particularly favored as they play a dynamic role in biological activities [43, 44]. Due to the vast reports available in the literature, below only some selected phenyl hydrazine as well as hydrazone based copper(II) exhibiting potentially better biological activity are discussed in detail.
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F13.png)
Figure 13.
Multi-functionality of hydrazone (red color) and its general synthesis route [17].
Idemudia and coworkers reported air-stable keto imine form of acylpyrazolone phenylhydrazones based ligands prepared by condensation of 4-acetyl and 4-benzoyl pyrazolone with dinitrophenylhydrazine as well as phenylhydrazine namely; benzoylphenylhydrazone (Bmpp-Ph), acetyldinitrophenylhydrazone (Ampp-Dh), as well as benzoyldinitrophenylhydrazone (Bmpp-Dh) and their transition metal complexes (Cu(II), Mn(II), Co(II), and Ni(II)) (Figure 14) [43]. All the complexes are under octahedral geometry and exhibited better biological activity than their respective ligands. Moreover in their extended work on salicylic hydrazide based transition metal complexes (Cu(II), Ni(II), Co(II), and Zn(II)) in a 1:1 molar ratio and their biological activities, where both ligand substituent and central metal atom dependent biological activity in which the efficacy of the metal complexes (Cu(II) > Zn(II) > Co(II) > Ni(II)) was higher than to that of the ligands (Figure 15) [44].
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F14.png)
Figure 14.
Proposed schematic structural representation of the metal complexes and crystal structure of acetyldinitrophenylhydrazone (Ampp-Dh) (top). Antioxidant activities of phenylhydrazones-based ligands and their respective metal complexes (bottom).
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F15.png)
Figure 15.
Structure (proposed) and activity relationship of the complexes (top). Graphical illustration of IC50 value of all the compounds (bottom).
Raman and coworkers reported an isatin-based hydrazone ligand prepared by condensation of 2,3,5-trichlorobenzaldehyde with isatin monohydrazone and their transition metal complexes (Cu(II), Ni(II), Co(II), and Zn(II)) in a 1:2 molar ratio for their potential biological activity (Figure 16) [45]. The results showed that all complexes exhibited effective oxidative DNA cleavage as well as promising antimicrobial activity where particularly copper(II) and zinc(II) complexes showed higher antimicrobial activity than the nickel(II) and cobalt(II) complexes.
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F16.png)
Figure 16.
Proposed structure and SC pBR322 DNA (0.3 μg) cleavage of by metal(II) complexes (0.30 mmol L−1) in the presence of H2O2 (100 μmol L−1) at pH 7.2. DNA control; DNA and H2O2; DNA + [CuL2Cl2]; DNA + ethanol (4 μL); are lanes 1–4 respectively; DNA + H2O2 + [CoL2Cl2], [CuL2Cl2], [ZnL2Cl2], and [NiL2Cl2], are lanes 5–8, respectively; DNA + H2O2 + ethanol + [CuL2Cl2]; DNA + H2O2 + SOD + [CuL2Cl2] are lane 9 and lane 10 respectively (top). Antibacterial and antifungal activities of ligands, complexes and control drugs (bottom) [45].
Lodyga-Chruscinska and coworkers reported a good chelating hesperetin based hydrazine ligand (HHSB) and its copper(II) complex exhibiting promising cytotoxic activity against cancer cells (normal (LLC-PK1) cell lines and tumor (HeLa and Caco-2)) [46, 47]. Moreover, further coordinating atom (changing O2N to ONS) and substituent changes using thiosemicarbazide (TSC) also exhibited similar cytotoxic activity confirming the versatility of the hesperetin based hydrazine ligand for chemical substituent modification (Figure 17).
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F17.png)
Figure 17.
Chelating ability of hesperetin based hydrazine ligand (HHSB) and its copper(II) complex proposed structure (top) [46]. Crystal structure of the hesperetin based hydrazine ligand with hydrogen bonding [46] and DNA damage of 4′,6-diamidino-2-phenylindole (DAPI) stained comets in the HeLa cells: (A) 50 μM cisplatin; (B) negative control; (C) 50 μM HHSB in Caco-2 cells; (D) 10 μM CuHHSB in LLC-PK1 cells; (E) 50 μM CuHHSB, and (F) 50 μM HHSB (bottom) [47].
Gatto and coworkers described pyridoxal-thiosemicarbazone and pyridoxal-S-allyldithiocarbazate hydrazone hydrazone ligands bearing ONS-donor atoms and their copper(II) complexes demonstrating promising potential anticancer activity (Figure 18) [48]. Interestingly, copper(II) complexes cytotoxic tests showed effective growth inhibition of both S-180 as well as Ehrlich tumor cells where enhancement of the cytotoxicity was also observed up on complexation of the ligands with copper(II) metal ions. Moreover, copper(II) complex (compound 5) demonstrated the death of the tumor cells confirming that pyridoxal derivative copper(II) complexes could be considered as great potential candidates for designing antitumor drugs which could be due to the presence of thiosemicarbazide pendant.
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F18.png)
Figure 18.
Effect of each copper (II) complex (1–5 with coordinated atoms color code: Blue N, red O, gold S, green Cl, maroon Br and cyan Cu) on the viability of the murine S-180 and Ehrlich cells treated with different concentrations with statistical
Naik and coworkers also reported bi-dentate indol based hydrazone ligand prepared by condensation of nicotinic acid hydrazide and indole-3-carboxaldehyde and their transition metal complexes (Cu(II), Co(II), Mn(II), and Ni(II)) under octahedral geometry for their potential biological activity (Figure 19) [49]. Of the transition metal complexes, copper(II) and cobalt (II) complexes exhibited better antibacterial as well as effective oxidative DNA cleavage activity. It is worthy to mention the importance of indol and nicotinic based hydrazone based ligands and their complexes suitability for designing bio-active compounds. Moreover, a similar trend where copper(II) and cobalt (II) complexes exhibited better antibacterial as well as effective DNA cleavage activity reported by Velladurai and coworkers using triazine based tridentate ligand prepared from 1,2,4-triazine and 1,4-Naphthoquinon pendants (Figure 20) [50].
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F19.png)
Figure 19.
Proposed structure of copper(II) complexes and percentage LDL oxidation inhibition by ligand and their metal complexes (4a–d) at 10 μM concentration (top). Cleavage of DNA (supercoiled pBR322 of 0.5 μg) by the Co(II), Ni(II) and Cu(III) complexes in a buffer at 37°C where DNA alone; DNA + 40 μl of cobalt complex + H2O2; DNA + 40 μl of Co(II); DNA + 60 μl of Co(II); DNA+ 40 μl of Ni(II); DNA + 60 μl of Ni(II); DNA + 40 μl of Cu(II); DNA + 60 μl of Cu(II) are lane 1–8 respectively while forms I-II are supercoiled as well as nicked circular DNA, respectively [49].
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F20.png)
Figure 20.
Proposed structure of transition metal complexes and their antibacterial activity [50].
Adimule and coworkers also reported benzimidazol based hydrazone bi-dentate ligand bearing NS donor atoms and its transition metal complexes (Cu(II), Ni(II), and Co(II)) for their DNA binding and antibacterial activity (Figure 21) [51]. In addition to antibacterial activity of all the complexes, among the transition metal complexes, copper (II) complex showed that an intercalative DNA binding and DNA cleavage in presence as well as absence of oxidant H2O2. was also observed.
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F21.png)
Figure 21.
Benzimidazol based hydrazone ligand and its proposed structure of transition metal complexes with inset: DNA binding where DNA control; DNA + H2O2; ligand + DNA; ligand + DNA + H2O2; Ni(II) + DNA; Ni(II) + DNA+ H2O2; Co(II) + DNA; Co(II) + DNA + H2O2; Cu(II) + DNA; Cu(II) + DNA+ H2O2 are lane 1-10 respectively (top). Antibacterial activity of transition metal(II) complexes with the control ciprofloxacin drug (a); and their Bar diagram representation of their antibacterial activity including the ligand (b) [51].
Moreover, a mixed-ligand copper(II) complexes of hydrazone-based ligands displaying efficient biological activities were also reported by Annaraj and coworkers where the vital role of co-ligands on cytotoxicity and DNA/protein interactions has been described in detail (Figure 22) [52]. The results of this work showed that the copper(II) complexes showed multi-functionality including anti-inflammatory, free-radical scavenging, antibacterial and DNA/protein interaction properties. More recently, Guo and coworkers also reported similar strategy, i.e. mixed-ligand hydrazone based copper(II) complexes and examined their potential anti-lung cancer activity (Figure 23) [53]. Results of this study revealed that the investigated mixed-ligand copper(II) complexes especially the complex with furan pendant was found playing a good role in inducing ROS-mediated mitochondrial pathway regulated A549 cancer cell apoptosis. In both mixed ligand copper(II), the observed multi-functionality could be due to the parent complex as well as the synergistic combination of the parent hydrazone ligand as well as the co-ligands which was also observed in other works [54].
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F22.png)
Figure 22.
Schematic representation of copper(II) complexes (1–4), the hydrazone ligand as well as the co-ligands (a). DNA cleavage (supercoiled pUC18 DNA) by copper(II) complexes 1–4 with buffer of pH = 7.14 at 37°C in the presence of ascorbic acid (ASC) as a reducing agent, where DNA control; DNA + ASC; lane 3: DNA + ASC + complex 1 (50 μM); DNA + ASC + complex 2 (200 μM); DNA + ASC + complex 3 (150 μM); DNA + ASC + complex 4 (300 μM) are lane 1–6, respectively (b). Antibacterial activity of complex 1 observed under the fluorescence microscope as well as stained using the live/dead BacLight kit against
![](/media/chapter/a043Y000010Jz6iQAC/a093Y00001gxHgpQAE/media/F23.png)
Figure 23.
Single crystal structure of the copper(II) complex and its schematic illustration of ROS-mediated mitochondrial pathway regulated A549 cancer cell apoptosis; (top) the 3D morphological changes on the A549 cells treated with the complex for 6 days with scale bar: 200 μm (middle) and wound healing results exhibited by the complex through inhibition of the A549 cells migration where pictures with scale bar: 200 μm taken at 0 h as well as 24 h, respectively (bottom) [53].
In general it have been demonstrated that hydrazone based copper (II) complexes have been extensively explored for their biological activities. Therefore, due to the vast literature report on hydrazone-based copper(II) complexes, only selected representative works are discussed in detail. From the above seminal representative works discussed, it is interesting to note that similar to the azo- based copper(II) complexes, hydrazone-based ligands processing indol, pyrazole, nicotinic, salicylic, isatin, thiozole, quinoline and pyridoxal moieties are relatively promising for designing copper(II) complexes with pronounced biological activity (Table 2).
Chemical formula* | Geometry | Characterization techniques | Biological activity | Refs. |
---|---|---|---|---|
[Cu(LNICO)2] | Octahedral | FTIR, UV–Vis, TGA, MS, XRD, SEM | Antibacterial | [55] |
[Cu(LINDO)(Cl)(H2O)2] | Octahedral | FTIR, UV–Vis, TGA, MS, XRD, SEM, ESR | Antibacterial Antifungal and Antioxidant | [56] |
[Cu(LSAL)2] | Octahedral | FTIR, UV–Vis, MS | Antibacterial Antifungal and Antioxidant | [57] |
[Cu(L2QUIN)] | Octahedral | FTIR, UV–Vis, MS, single crystal XRD | Anticancer | [58] |
[CuLPYRA(phen)(CH3OH)][CuLPYRA(phen)]·CH3CH2OH·CH3OH | Octahedral and square pyramidal | FTIR, UV–Vis, MS, single crystal XRD | Anticancer | [59] |
[Cu(LISAT)2Cl2] | Octahedral | FTIR, UV–Vis, TGA, MS, EPR | Antibacterial Antifungal and DNA cleavage | [45] |
Table 2.
Copper(II) complexes of hydrazine-based ligands and their biological activities.
The abbreviated expressions in subscript position; NICO, SAL, INDO, QUI, PYRA, and stands for nicotinic, salicylic, indole, quinoline, pyrazole, isatin, and their derivatives respectively, for more structural details of the ligands, please refer the original article from the provided references.
3. Conclusions and future outlooks
The presented chapter provides an over view of the up-to-date advances and perspectives of azo- and hydrazine-based copper(II) complexes and their biological activities. These complexes have been proved to be indispensable class of bio-active compounds with broad spectrum of biological activities such as anticancer, antibacterial, antifungal, DNA cleavage, etc. Moreover, azo- and hydrazine-based ligands bearing salicylic, thiosemicarbazide, pyridinone, pyrazole, thiazole, indole, isatin, quinoline, nicotinic, and their derivatives are found to be promising to design bio-active copper(II) compounds. Therefore, future research works are expected to explore on novel azo- and hydrazine-based copper(II) complexes owing broad spectrum biological activities accompanied with less toxicity. Biologically active starting materials such as hesperetin, curcumin and the like are recommended to rationally design the chelating azo- and hydrazine-based ligands. Additionally, chromophore tagged azo- and hydrazine-based ligands are also expected to expand the multifunctionality of their respective copper(II) bio-active complexes. Finally, the prospect of copper(II) complexes of azo- and hydrazine-based bio-active copper(II) complexes is a bright future which are expected to replace the conventional drugs which are suffering from side effects as well as pathogenic resistance. However, a collaborative work between Chemists, Biochemists as well as molecular Biologists is still needed to realize the promising biological activities of such compounds to the commercialization level. Although the research works undergoing in academia are encouraging, a collaborative work from multidisciplinary experts is a must to realize the industrialization of such auspicious compounds.
References
- 1.
Santini C, Pellei M, Gandin V, Porchia M, Tisato F, Marzano C. Advances in copper complexes as anticancer agents. Chemical Reviews. 2014; 114 (1):815-862 - 2.
Zehra S, Tabassum S, Arjmand F. Biochemical pathways of copper complexes: Progress over the past 5 years. Drug Discovery Today. 2021; 26 (4):1086-1096 - 3.
Ruiz LM, Libedinsky A, Elorza AA. Role of copper on mitochondrial function and metabolism. Frontiers in Molecular Biosciences. 2021:8 - 4.
Bost M, Houdart S, Oberli M, Kalonji E, Huneau JF, Margaritis I. Dietary copper and human health: Current evidence and unresolved issues. Journal of Trace Elements in Medicine and Biology. 2016; 35 :107-115 - 5.
Denoyer D, Masaldan S, La Fontaine S, Cater MA. Targeting copper in cancer therapy: “Copper That Cancer”. Metallomics. 2015; 7 (11):1459-1476 - 6.
Storr T, Thompson KH, Orvig C. Design of targeting ligands in medicinal inorganic chemistry. Chemical Society Reviews. 2006; 35 (6) - 7.
Erxleben A. Interactions of copper complexes with nucleic acids. Coordination Chemistry Reviews. 2018; 360 :92-121 - 8.
Desbouis D, Troitsky IP, Belousoff MJ, Spiccia L, Graham B. Copper(II), zinc(II) and nickel(II) complexes as nuclease mimetics. Coordination Chemistry Reviews. 2012; 256 (11-12):897-937 - 9.
Festa RA, Thiele DJ. Copper: An essential metal in biology. Current Biology. 2011; 21 (21):R877-R883 - 10.
Brahma U, Kothari R, Sharma P, Bhandari V. Antimicrobial and anti-biofilm activity of hexadentated macrocyclic complex of copper(II) derived from thiosemicarbazide against Staphylococcus aureus. Scientific Reports. 2018; 8 (1):8050 - 11.
Gordon NA, McGuire KL, Wallentine SK, Mohl GA, Lynch JD, Harrison RG, et al. Divalent copper complexes as influenza A M2 inhibitors. Antiviral Research. 2017; 147 :100-106 - 12.
Malis G, Geromichalou E, Geromichalos GD, Hatzidimitriou AG, Psomas G. Copper(II) complexes with non–steroidal anti–inflammatory drugs: Structural characterization, in vitro and in silico biological profile. Journal of Inorganic Biochemistry. 2021; 224 :111563 - 13.
Gandra RM, Carron PM, Fernandes MF, Ramos LS, Mello TP, Aor AC, et al. Antifungal potential of copper(II), Manganese(II) and silver(I) 1,10-phenanthroline chelates against multidrug-resistant fungal species forming the Candida haemulonii complex: Impact on the planktonic and biofilm lifestyles. Frontiers in Microbiology. 2017; 8 :1257 - 14.
Ndagi U, Mhlongo N, Soliman ME. Metal complexes in cancer therapy – An update from drug design perspective. Drug Design, Development and Therapy. 2017; 11 :599-616 - 15.
Pervaiz M, Sadiq S, Sadiq A, Younas U, Ashraf A, Saeed Z, et al. Azo-Schiff base derivatives of transition metal complexes as antimicrobial agents. Coordination Chemistry Reviews. 2021; 447 :214128 - 16.
Gebretsadik T, Yang Q , Wu J, Tang J. Hydrazone based spin crossover complexes: Behind the extra flexibility of the hydrazone moiety to switch the spin state. Coordination Chemistry Reviews. 2021; 431 :213666 - 17.
Su X, Aprahamian I. Hydrazone-based switches, metallo-assemblies and sensors. Chemical Society Reviews. 2014; 43 (6):1963-1981 - 18.
Kumari P, Choudhary M, Kumar A, Yadav P, Singh B, Kataria R, et al. Copper(II) Schiff base complexes: Synthetic and medicinal perspective. Inorganic Chemistry Communications. 2023; 158 (P1):111409 - 19.
Joshi SD, Kumar D, Dixit SR, Tigadi N, More UA, Lherbet C, et al. Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes. European Journal of Medicinal Chemistry. 2016; 121 :21-39. DOI: 10.1016/j.ejmech.2016.05.025 - 20.
Peng YX, Zhao XL, Xu D, Qian HF, Huang W. In situ metal-ion complexation and H2O2 oxidation for a pyridine-2,6-dione based disperse yellow dye. Dyes and Pigments. 2017; 136 :559-568 - 21.
Al-Sulami AI, Basha MT, Althagafy HS, Al-Zaydi KM, Davaasuren B, Al-Kaff NS, et al. Azo-based multifunctional molecules and their copper(II) complexes as potential inhibitors against Alzheimer’s disease: XRD/Hirshfeld analysis/DFT/molecular docking/cytotoxicity. Inorganic Chemistry Communications. 2022; 142 :109535 - 22.
Turomsha IS, Gvozdev MY, Loginova NV, Ksendzova GA, Osipovich NP. Synthesis, characterization and biological activity of Hydrazones and their copper(II) complexes. Chemical Processing. 2023; 12 (1):73 - 23.
Hassan AM, Said AO, Heakal BH, Younis A, Aboulthana WM, Mady MF. Green synthesis, characterization, antimicrobial and anticancer screening of new metal complexes incorporating schiff base. ACS Omega. 2022; 7 :32418-32431 - 24.
Sarigul M, Sari A, Kose M, McKee V, Elmastas M, Demirtas I, et al. New bio-active azo-azomethine based Cu(II) complexes. Inorganica Chimica Acta. 2016; 444 :166-175. DOI: 10.1016/j.ica.2016.01.042 - 25.
Venugopal N, Krishnamurthy G, Bhojyanaik HS, Giridhar M. Novel bioactive azo-azomethine based Cu (II), Co (II) and Ni(II) complexes, structural determination and biological activity. Journal of Molecular Structure. 2019; 1191 :85-94. DOI: 10.1016/j.molstruc.2019.04.022 - 26.
Mallikarjuna NM, Keshavayya J, Ravi BN. Synthesis, spectroscopic characterization, antimicrobial, antitubercular and DNA cleavage studies of 2-(1H-indol-3-yldiazenyl)-4, 5, 6, 7-tetrahydro-1, 3-benzothiazole and its metal complexes. Journal of Molecular Structure. 2018; 1173 :557-566. DOI: 10.1016/j.molstruc.2018.07.007 - 27.
Matada MN, Jathi K, Geoffry K, Berenkere Nagarajappa R, Chander TH. Synthesis, characterization, and biological evaluation of 4-[(4-hydroxy-7-methyl-1,3-benzothiazol-2-yl) diazenyl]-5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one and its metal complexes. Journal of Coordination Chemistry. 2020; 73 (10):1554-1572. DOI: 10.1080/00958972.2020.1787393 - 28.
Maliyappa MR, Keshavayya J. Cu(II), Co(II), Ni(II), Zn(II) and Cd(II) complexes of novel azo ligand 6-hydroxy-4 methyl-2 oxo-5-[(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)diazenyl]-1,2-dihydropyridine 3-carbonitrile as potential biological agents: Synthesis and spectroscopic characte. Chemical Papers. 2022; 76 (6):3485-3498. DOI: 10.1007/s11696-022-02101-7 - 29.
Ramashetty KB, Channabasappa PM, Seetyanaik BH, Ereshanaik RV, Nayak ANPNH, et al. Fabrication, depiction, DNA interaction, anti-bacterial, DFT and molecular docking studies of Co(II) and Cu(II) complexes of 3-methyl-1-phenyl-4-[(E)-(pyridin-2-yl)diazenyl]-1H-pyrazol-5-ol ligand. Nucleosides, Nucleotides and Nucleic Acids. 2021; 41 (1):1-22. DOI: 10.1080/15257770.2021.1991373 - 30.
Basha MT, Al-Sulami AI, Althagafy HS, Alamshany ZM, Abdel-Rahman LH, Shehata MR, et al. Synthesis and characterization of novel heterocyclic diazenyl pyridinone copper(II) complexes with antimicrobial, antioxidant, and anticancer properties. Applied Organometallic Chemistry. 2023; 37 (2):1-19 - 31.
Lađarević J, Radovanović L, Božić B, Mašulović A, Lunić T, Radovanović Ž, et al. New copper (II) complexes derived from azo pyridone dyes: Structure characterization, thermal properties, and molecular docking studies. Applied Organometallic Chemistry. 2023; 37 (10):1-17 - 32.
Kasare MS, Dhavan PP, Jadhav BL, Pawar SD. Synthesis of azo Schiff Base ligands and their Ni(II), Cu(II) and Zn(II) metal complexes as highly-active antibacterial agents. ChemistrySelect. 2019; 4 (36):10792-10797 - 33.
Sahan F, Kose M, Hepokur C, Karakas D, Kurtoglu M. New azo-azomethine-based transition metal complexes: Synthesis, spectroscopy, solid-state structure, density functional theory calculations and anticancer studies. Applied Organometallic Chemistry. 2019; 33 (7):1-13 - 34.
Alaghaz ANMA, Zayed ME, Alharbi SA. Synthesis, spectral characterization, molecular modeling and antimicrobial studies of tridentate azo-dye Schiff base metal complexes. Journal of Molecular Structure. 2015; 1084 :36-45. DOI: 10.1016/j.molstruc.2014.12.013 - 35.
Zabin SA, Jammali M, Alzahrani AA. The bivalent Cu, Ni and Zn complexes of unsymmetrical ONO tridentate Schiff Base ligands derived from 2-aminobenzoic acid: Antimicrobial and Molluscicidal activity. Journal of Organic & Inorganic Chemistry. 2018; 4 (2):6 - 36.
Anitha C, Sumathi S, Tharmaraj P, Sheela CD. Synthesis, characterization, and biological activity of some transition metal complexes derived from novel Hydrazone azo Schiff Base ligand. International Journal of Inorganic Chemistry. 2011; 2011 :1-8 - 37.
Refat MS, El-Deen IM, Amin RR, El-Ghol S. Spectroscopic studies and biological evaluation of some transition metal complexes of a novel Schiff base ligands derived from 5-arylazo-salicyladehyde and o-amino phenol. Toxicological and Environmental Chemistry. 2010; 92 (6):1093-1110 - 38.
Azam M, Al-Resayes SI, Wabaidur SM, Altaf M, Chaurasia B, Alam M, et al. Synthesis, structural characterization and antimicrobial activity of Cu(II) and Fe(III) complexes incorporating azo-azomethine ligand. Molecules. 2018; 23 (4):813 - 39.
Refat MS, El-Deeny IM, Anwer ZM, El-Ghol S. Spectroscopic studies and biological evaluation of some transition metal complexes of Schiff-base ligands derived from 5-arylazo-salicylaldehyde and thiosemicarbazide. Journal of Coordination Chemistry. 2009; 62 (10):1709-1718 - 40.
Mali SN, Thorat BR, Gupta DR, Pandey A. Mini-review of the importance of hydrazides and their derivatives-synthesis and biological activity. Engineering Proceedings. 2021; 11 (1):21 - 41.
Brady OL, Elsmie GV. The use of 2:4-dinitrophenylhydrazine as a reagent for aldehydes and ketones. The Analyst. 1926; 51 (599):77-78 - 42.
Prokai L, Szarka S, Wang X, Prokai-Tatrai K. Capture of the volatile carbonyl metabolite of flecainide on 2,4-dinitrophenylhydrazine cartridge for quantitation by stable-isotope dilution mass spectrometry coupled with chromatography. Journal of Chromatography. A. 2012; 1232 :281-287 - 43.
Idemudia OG, Sadimenko AP, Hosten EC. Metal complexes of new bioactive pyrazolone phenylhydrazones; crystal structure of 4-acetyl-3-methyl-1-phenyl-2-pyrazoline-5-one phenylhydrazone ampp-ph. International Journal of Molecular Sciences. 2016; 17 (5) - 44.
Arora T, Devi J, Boora A, Taxak B, Rani S. Synthesis and characterization of hydrazones and their transition metal complexes: Antimicrobial, antituberculosis and antioxidant activity. Research on Chemical Intermediates. 2023; 49 (11):4819-4843. DOI: 10.1007/s11164-023-05116-1 - 45.
Raman N, Pothiraj K, Baskaran T. DNA-binding, oxidative DNA cleavage, and coordination mode of later 3d transition metal complexes of a Schiff base derived from isatin as antimicrobial agents. Journal of Coordination Chemistry. 2011; 64 (22):3900-3917 - 46.
Lodyga-Chruscinska E, Symonowicz M, Sykula A, Bujacz A, Garribba E, Rowinska-Zyrek M, et al. Chelating ability and biological activity of hesperetin Schiff base. Journal of Inorganic Biochemistry. 2015; 143 :34-47. DOI: 10.1016/j.jinorgbio.2014.11.005 - 47.
Sykuła A, Nowak A, Garribba E, Dzeikala A, Rowińska-Żyrek M, Czerwińska J, et al. Spectroscopic characterization and biological activity of Hesperetin Schiff bases and their Cu(II) complexes. International Journal of Molecular Sciences. 2023; 24 (1):761 - 48.
Gatto CC, Chagas MAS, Lima IJ, Mello Andrade F, Silva HD, Abrantes GR, et al. Copper(II) complexes with pyridoxal dithiocarbazate and thiosemicarbazone ligands: Crystal structure, spectroscopic analysis and cytotoxic activity. Transition Metal Chemistry. 2019; 44 (4):329-340. DOI: 10.1007/s11243-018-00299-8 - 49.
Neelufar RJ, Ankali KN, Naik N, Nuthan BR, Satish S. The Mn(II), Co(II), Ni(II) and Cu(II) complexes of (Z)-N’((1H-indol-3-yl)methylene)nicotinohydrazide Schiff base: Synthesis, characterization and biological evaluation. Journal of the Iranian Chemical Society. 2022; 19 (9):3993-4004. DOI: 10.1007/s13738-022-02580-1 - 50.
Priya Dharsini GR, Thanaraj C, Velladurai R. Metal chelates of tridentate (NNO) 1,2,4-Triazine Schiff Base: Synthesis, Physico-chemical investigation and pharmacological screening. Journal of Inorganic and Organometallic Polymers and Materials. 2020; 30 (7):2315-2322. DOI: 10.1007/s10904-019-01413-8 - 51.
Adimule V, Yallur BC, Kamat V, Krishna PM. Characterization studies of novel series of cobalt (II), nickel (II) and copper (II) complexes: DNA binding and antibacterial activity. Journal of Pharmaceutical Investigation. 2021; 51 (3):347-359. DOI: 10.1007/s40005-021-00524-0 - 52.
Kathiresan S, Mugesh S, Annaraj J, Murugan M. Mixed-ligand copper(II) Schiff base complexes: The vital role of co-ligands in DNA/protein interactions and cytotoxicity. New Journal of Chemistry. 2017; 41 (3):1267-1283 - 53.
Wu YR, Hou LX, Lan JF, Yang F, Huang GJ, Liu W, et al. Mixed-ligand copper(II) hydrazone complexes: Synthesis, structure, and anti-lung cancer properties. Journal of Molecular Structure. 2023; 1279 :134986. DOI: 10.1016/j.molstruc.2023.134986 - 54.
Abebe A, Bayeh Y, Belay M, Gebretsadik T, Thomas M, Linert W. Mono and binuclear cobalt(II) mixed ligand complexes containing 1,10-phenanthroline and adenine using 1,3-diaminopropane as a spacer: Synthesis, characterization, and antibacterial activity investigations. Future Journal of Pharmaceutical Sciences. 2020; 6 (1):13 - 55.
Arora T, Devi J, Dubey A, Tufail A, Kumar B. Spectroscopic studies, antimicrobial activity, and computational investigations of hydrazone ligands endowed metal chelates. Applied Organometallic Chemistry. 2023; 37 (9):e7209 - 56.
Yernale NG, Matada BS, Vibhutimath GB, Biradar VD, Karekal MR, Udayagiri MD, et al. Indole core-based Copper(II), Cobalt(II), Nickel(II) and Zinc(II) complexes: Synthesis, spectral and biological study. Journal of Molecular Structure. 2022; 1248 :131410. DOI: 10.1016/j.molstruc.2021.131410 - 57.
Yernale NG, Suliphuldevara Mathada B, Shivprasad S, Hiremath S, Karunakar P, Venkatesulu A. Spectroscopic, theoretical and computational investigations of novel benzo[b]thiophene based ligand and its M(II) complexes: As high portentous antimicrobial and antioxidant agents. Spectrochimica Acta Part A: Molecular Spectroscopy. 2023; 302 (March):123114. DOI: 10.1016/j.saa.2023.123114 - 58.
Du Y, Chen W, Fu X, Deng H, Deng J. Synthesis and biological evaluation of heterocyclic hydrazone transition metal complexes as potential anticancer agents. RSC Advances. 2016; 6 (111):109718-109725 - 59.
Nurmamat M, Yan H, Wang R, Zhao H, Li Y, Wang X, et al. Novel copper(II) complex with a 4-Acylpyrazolone derivative and Coligand induce apoptosis in liver cancer cells. ACS Medicinal Chemistry Letters. 2021; 12 (3):467-476